Warning letter
PrimaPharm Inc.: warning letter of Oct 31, 2008
FDA warning letter UCM1048078 · Los Angeles District Office
Key facts
| Reference number | UCM1048078 |
|---|---|
| Company | PrimaPharm Inc. |
| Subject | Unapproved New Drug/Adulterated/Misbranded |
| Issue date | Oct 31, 2008 |
| Posted date | Oct 31, 2008 |
| Issuing office | Los Angeles District Office |
| Product type | Drugs |
| CFR sections cited | 201.115, 211, 211.192, 330, 211.42(c)(10)(v), 211.113(b), 211.165(e) |
| Country | 3 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: